News | March 21, 2022
Hetero gets CDSCO approval to manufacture and sell Sputnik Light in India
Sputnik Light is the first component of Sputnik V
Sputnik Light is the first component of Sputnik V
Inconsistent antibody performance is a significant challenge for researchers and sits at the heart of the reproducibility crisis observed in biomedical research
Biolexis will also leverage the capabilities of Strides Group for launching this vaccine across regions where the group has a deep market presence and established relationships
First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older
Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer
Under the agreement, both companies will conduct collaborative research utilizing NuclixBio's proprietary circular mRNA platform named 'ringRNA’ to develop novel mRNA therapeutics that can generate PharmAbcine's antibodies
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
Subscribe To Our Newsletter & Stay Updated
